5-Chloro-N-(4-chlorophenyl)-1-[(2,6-dichlorophenyl)methyl]-6-oxo-1,6-dihydropyridine-3-carboxamide

Catalog No. :
ACASXH054
CAS No. :
339023-91-5
Molecular Formula :
C19H12Cl4N2O2
Molecular Weight :
442.13

IUPAC Name:5-chloro-N-(4-chlorophenyl)-1-(2,6-dichlorobenzyl)-6-oxo-1,6-dihydropyridine-3-carboxamide

5-Chloro-N-(4-chlorophenyl)-1-[(2,6-dichlorophenyl)methyl]-6-oxo-1,6-dihydropyridine-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-N-(4-chlorophenyl)-1-[(2,6-dichlorophenyl)methyl]-6-oxo-1,6-dihydropyridine-3-carboxamide
IUPAC Name5-chloro-N-(4-chlorophenyl)-1-(2,6-dichlorobenzyl)-6-oxo-1,6-dihydropyridine-3-carboxamide
MDL No.MFCD00140103
Molecular FormulaC19H12Cl4N2O2
Molecular Weight442.13
SMILESO=C(C(C=C1Cl)=CN(CC2=C(Cl)C=CC=C2Cl)C1=O)NC3=CC=C(Cl)C=C3
InChI KeyAZOWOCXCVIHOGL-UHFFFAOYSA-N
Synonym5-CHLORO-N-(4-CHLOROPHENYL)-1-(2,6-DICHLOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBOXAMIDE;5-chloro-N-(4-chlorophenyl)-1-[(2,6-dichlorophenyl)methyl]-6-oxo-1,6-dihydropyridine-3-carboxamide;3-Pyridinecarboxamide, 5-chloro-N-(4-chlorophenyl)-1-[(2,6-dichlorophenyl)methyl]-1,6-dihydro-6-oxo-
CAS No.339023-91-5

Synthetic Route by SureRoute

1. ACASXH054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACASXH054 route product structure diagram
    ACASXH054339023-91-5
Inquiry

2. ACASXH054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACASXH054 route product structure diagram
    ACASXH054339023-91-5
Inquiry

Comments (0)